Logo

SeqWright to Help Develop VisiGen s Sequencing Technology

Nov 09, 2004

NEW YORK, Nov. 9 (GenomeWeb News) - VisiGen Biotechnologies and SeqWright are partnering to develop VisiGen's DNA sequencing technology, the Houston-based companies said today.

 

As part of the alliance, SeqWright will pay VisiGen an undisclosed amount of cash in exchange for VisiGen stock. SeqWright, which provides DNA sequencing and other molecular biology services, will contribute to developing and commercializing VisiGen's rapid sequencing technology.

 

Both companies are housed in the WilburyBiotechnologyCenterin Houston.

Breaking News
The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.